| Metric | Q3 2026 | Q3 2025 |
|---|---|---|
| Revenue | 5.1 | 1.3 |
| Gross profit | 0.8 | 0.2 |
| Profit before tax | -29.7 | -13.1 |
| Net income | -30.9 | -12.9 |
| EPS (diluted, $ a share) | $-0.21 | $-0.14 |
A dash means the filing did not report that period. Growth is not shown when either period was a loss. Figures from the filing's XBRL data.
| Revenue, year on year | +303.1% |
|---|---|
| Gross margin | 15.5% |
10-Q filed with the SEC, NASDAQ: ASPI. Figures from the filing's XBRL data; summary written with AI assistance from the filing.
ASP Isotopes Inc.: key numbers
- Share price
- $1.54Close, Nov 16
- Market cap
- $194M
- Shares outstanding
- 125.9MLatest SEC cover page
- Sector
- Industrial Applications and Services
- Industry
- Miscellaneous Chemical ProductsSIC 2890
Today's reference numbers, updated daily. Not a valuation or a recommendation.
More from ASP Isotopes Inc.
All →ASP Isotopes Business Update
ASP Isotopes announced that its subsidiary Renergen Limited has achieved stable liquid helium production at the Virginia Gas Project in South Africa. The facility is now accumulating liquid helium in cryogenic storage ahead of initial deliveries to contracted offtakers, with a ramp-up to nameplate capacity expected during Q4 2026.
- Counterparty
- Renergen Limited
ASP Isotopes CFO Heather Kiessling Sells $47.8K of Stock
Heather Kiessling, CFO, sold 21,830 shares of ASP Isotopes Inc. at $2.19 a share, worth $47.8K in total on Oct 16, 2026. Shares held after the trade: 1,504,422 (-1.4%).
- Value
- $47.8K
- Shares
- 21,830
- Price
- $2.19
- Role
- CFO
- Holding change
- -1.4%
- Trade date
- Oct 16, 2026
ASP Isotopes COO Robert Ainscow Sells $47.6K of Stock
Robert Ainscow, COO, sold 22,500 shares of ASP Isotopes Inc. at $2.11 a share, worth $47.6K in total on Oct 14, 2026. Shares held after the trade: 2,225,941 (-1.0%).
- Value
- $47.6K
- Shares
- 22,500
- Price
- $2.11
- Role
- COO
- Holding change
- -1.0%
- Trade date
- Oct 14, 2026
ASP Isotopes Partnership with Nuclear Energy Corporation of South Africa SOC Limited
ASP Isotopes' subsidiary Quantum Leap Energy (QLE) signed a binding Heads of Agreement with Necsa to form a joint venture (80% QLE / 20% Necsa) to develop and operate a commercial-scale HALEU production facility in South Africa. The venture will utilize QLE's enrichment technology and Necsa's Pelindaba site infrastructure, supported by existing offtake agreements with TerraPower.
- Counterparty
- Nuclear Energy Corporation of South Africa SOC Limited (Necsa)
ASP Isotopes M&A Deal with ENDRA Life Sciences Inc.
ASP Isotopes Inc. provided a status update on its pending merger with ENDRA Life Sciences Inc., noting that ENDRA has filed a Registration Statement on Form S-4 regarding the transaction. The deal involves the merger of ASPI's subsidiary, Noble Africa LLC, with a subsidiary of ENDRA, with Noble Africa surviving as a wholly-owned subsidiary of ENDRA.
- Counterparty
- ENDRA Life Sciences Inc.
ASP Isotopes Director Robert John Andrew Ryan Buys $40.2K of Stock
Robert John Andrew Ryan, Director, bought 15,000 shares of ASP Isotopes Inc. at $2.68 a share, worth $40.2K in total on Sep 30, 2026. Shares held after the trade: 675,222 (+2.3%).
- Value
- $40.2K
- Shares
- 15,000
- Price
- $2.68
- Role
- Director
- Holding change
- +2.3%
- Trade date
- Sep 30, 2026